VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 0993519
Sex: F
Age:
State: AZ

Vax Date: 01/09/2021
Onset Date: 01/01/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data: Test Date: 20210112; Test Name: Nasal Swab; Test Result: Negative ; Test Name: platelets; Result Unstructured Data: Test Result:high

Allergies:

Symptoms: high platelets; fatigue; sharp muscle pains in hands and elbows; Headaches; nausea; Canker sore on my tongue; had a sizable bruise; This is a spontaneous report from a contactable other healthcare professional (patient). A 41-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at left arm on 09Jan2021 11:45 AM at single dose for COVID-19 immunization. Medical history and concomitant medication were not reported. Patient is not pregnant. Patient previously took the first dose of BNT162B2 at single dose for COVID-19 immunization. Patient have had a lot of fatigue, sharp muscle pains in hands and elbows at day 9 post injection (17Jan2021). Patient was now developing a Canker sore on her tongue as a fellow coworker had the same reaction (Jan2021). Patient have high platelets and have had a sizable bruise for 9 days. Headaches and nausea were present at three hours post injection (09Jan2021). AE resulted in doctor or other healthcare professional office/clinic visit. No COVID prior vaccination. No COVID tested post vaccination. covid test type post vaccination included Nasal Swab on 12Jan2021 with test result of Negative. No treatment received for the events. Outcome of the events was unknown. Information on the Lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0993520
Sex: F
Age:
State:

Vax Date: 10/01/2018
Onset Date:
Rec V Date: 02/02/2021
Hospital:

Lab Data: Test Date: 2018; Test Name: CBC; Result Unstructured Data: Test Result:everything was ok; Test Date: 2018; Test Name: white count; Result Unstructured Data: Test Result:elevated; Comments: The white count was elevated a little bit

Allergies:

Symptoms: swollen shoulder to her elbow; slight fever; it was a little red. Like palm size redness; white count was elevated a little bit; skin reaction; This is a spontaneous report from a contactable Pharmacist. A 65-year-old female Pharmacist (patient) received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13, Solution for injection in pre-filled syringe, Batch/lot number: Not Provided) via an unspecified route of administration in Oct2018 at single dose for immunization. Historical vaccine included flu shot (Most of the time with the flu shot she has muscle pain) for immunization and had muscle pain. Concomitant medications were not reported. She got the Prevnar 13 shot two years ago and had a bad reaction. It was a week later she had a reaction. She experienced a swollen shoulder to her elbow on an unspecified date in 2018. She went to the doctor for the check up and was provided with two antibiotics. The doctor said that it could be an infection, but not at the injection site. She went to her doctor recently to see if she can take the COVID vaccine. She was asking if it was safe and if she was able to take the COVID vaccine. She was 65 years of age. She was a pharmacist. Caller states in Oct2018 she received Prevnar 13 shot and it was made by Pfizer. She had the shot on Monday. Most of the time with the flu shot she has muscle pain. When she got the Prevnar shot on Monday, on Tuesday she had a slight fever and it was a little red on an unspecified date in 2018. Like palm size redness on an unspecified date in 2018. She let it go because previously some other shots would have the same thing. On Friday, she had concern because her doctor wasn't going to be available, so he ordered a CBC and everything was ok. She went to the ER on Saturday because the swelling got bigger. The white count was elevated a little bit on an unspecified date in 2018. They said to wait and see. They drew the line and she went home. On Sunday, it was still there and the area was quite big. She went back to the ER. They gave her Septra DS, two BID (twice a day). She was still concerned and she called doctor. He added Keflex, 1 gram QID (four times a day). He advised her if it wasn't better to go see him on Wednesday. By Tuesday it had gone down. Her dad was sick and she rushed back to (address). With COVID she was concerned. Her doctor thinks she could have just been getting an infection and he doesn't think it is an allergy reaction. She was still concerned. Were there any documentation of issues with allergies to Prevnar 13 with COVID vaccine? Lot of people have skin reactions with Prevnar 13, she googled it and from chatting with friends and family. It depends on the degree. This kind of skin reaction was the first time for her on an unspecified date in 2018. Normally it would stay there for a couple of days. It just happened to be a Pfizer vaccine. She doesn't think there are any components that are similar to that. She wants to know if she can get the COVID vaccine. Are there any precautions she should watch for or wait? Apparently it was not an allergy to use Epipen or things like. Caller states her reaction to Prevnar 13 was two years and three months ago. She feels lots of people have skin reactions. She wants to be transferred to Medical Information. Caller declined to report. Should she wait for more safety report to come out? It was mRNA, lipid, and PEG. She doesn't have problems with Miralax. Caller was a pharmacist, retired 2 months ago, who asks should she get the vaccine? Caller reports that she was 67 yo who has a history of a skin reaction on her left arm after receiving the Prevnar 13 vaccine. She reports that this occurred 27 months ago. She reports that her doctor said it looked like an infection from the injection, she states that she "was prescribed Septra DS 2 BID (twice a day) and it got better". She was concerned about getting the covid vaccine after having that reaction but also reports that her MD doesn't think she should worry about it. She calls today for additional guidance. Outcome of events swollen shoulder to her elbow was not recovered, slight fever, it was a little red. Like palm size redness, skin reaction was recovering; while with other event was unknown. No follow-up attempts are needed. Information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: There is a reasonable possibility that the events pyrexia and vaccination site erythema was related to PREVNAR 13 use based on known drug safety profile. Based on the temporal relationship, the association between the other events with PREVNAR 13 can not be completely excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0993521
Sex: F
Age:
State: FL

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: a knot in her arm; sore to the touch; Exhibiting flu-like symptoms; Fever; Severe body aches; Runny nose; Cough; Anaphylaxis; This is a spontaneous report from a contactable consumer(patient). A 49-year-old female patient received second dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EL3246), intramuscular in right bicep(arm) on 13Jan2021 around 16:15 at single dose for preventative. Medical history included high blood pressure from 2016 and ongoing. Concomitant medication included ongoing chlortalidone for high blood pressure. She received first dose of covid vaccine BNT162B2 (Lot: EL0140) on 23Dec2020 around 13:00., in right bicep(arm), a little above where she received this second dose for covid-19 immunization, she previously received flu shot for immunization and had a knot in her arm where it is tender to the touch and sore. She had an anaphylaxis event directly after her shot on 13Jan2021, she was kind of knocked out for the anaphylaxis event and her body was hurting. She was not sure if it was from the shot or from the trauma anaphylaxis event. She received an epi shot in the clinic, diphenhydramine (BENADRYL)into her arm. She was taken to the ER(Emergency Room) where she stayed till about 9:30pm. She was not admitted. Anaphylaxis recovered on 13Jan2021. She also stated that she got sick after the shot, she was exhibiting flu-like symptoms, she never lost her taste or smell, she had a fever, severe body aches, runny nose, and a cough. These symptoms started the next day on the 14Jan2021 and got worse on the 15Jan2021, on 17Jan2021, She feeling better morning and recovered completely by the time she went to bed in regards to her flu-like symptoms, she felt like herself and normal. She felt rested. This morning she felt good. Treatment included paracetamol (TYLENOL) and she was taking diphenhydramine every night since the anaphylaxis occurred. She still had a knot in her arm that it was very sore to the touch which she stated was pretty common even with flu shot(not know the name of the flu shot or have lot, NDC, or expiration date) where it was tender to the touch and sore. There was no relevant test. Outcome of anaphylaxis was recovered on 13Jan2021, of a knot in her arm, sore to the touch was unknown, of other events was recovered on 17Jan2021.

Other Meds: CHLORTHALIDONE

Current Illness: Blood pressure high

ID: 0993522
Sex: F
Age:
State: CT

Vax Date: 01/18/2021
Onset Date: 01/18/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Exhausted; sore; headache; This is a spontaneous report from a contactable consumer. A 49-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 18Jan2021 at single dose for COVID-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced Exhausted, sore, headache on 18Jan2021. Outcome of events was unknown. No follow up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 0993523
Sex: F
Age:
State: NY

Vax Date: 01/18/2021
Onset Date: 01/19/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data: Test Date: 20210119; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptoms: Fever; body aches; severe exhaustion; dizziness; sweating; cold chills; shortness of breath; sore swollen throat; sore swollen throat; This is a spontaneous report from a contactable health professional, the patient. A 25-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot: EL32A) via an unspecified route of administration in the left arm on 18Jan2021 at 16:00 (at the age of 25-years-old) for COVID-19 immunization. Medical history included gastroparesis. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included celecoxib (CELEXA), alprazolam (ATARAX), ethinylestradiol/levonorgestrel (AVIANE). The patient did not receive other vaccines within 4 weeks prior to the BNT162B2 vaccine. The patient previously took amoxicillin and experienced allergies; and received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot: EK5730) on 28Dec2020 at 14:30 (at an unspecified age) in the left arm for COVID-19 immunization. On 19Jan2021 at 01:00, the patient experienced fever, body aches, severe exhaustion, dizziness, sweating, cold chills, shortness of breath, sore swollen throat. The patient did not receive any treatment for the events. Since the vaccination, the patient had been tested for COVID-19 via nasal swab on 19Jan2021 with negative results. The clinical outcome of Fever, body aches, severe exhaustion, dizziness, sweating, cold chills, shortness of breath, sore swollen throat was not resolved.

Other Meds: CELEXA [CELECOXIB]; ATARAX [ALPRAZOLAM]; AVIANE

Current Illness:

ID: 0993524
Sex: F
Age:
State: TX

Vax Date: 01/18/2021
Onset Date: 01/18/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fatigue; chills; body aches; headache; This is a spontaneous report from a contactable nurse. A 49-year-old female patient received the second dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: Ej1686), in a hospital intramuscularly in the left arm on 18Jan2021 at 09:00 at 49-years-old at a single dose for COVID-19 immunization. Medical history included type 2 diabetes mellitus (Dm2 controlled) from an unknown date and unknown if ongoing. Concomitant medications included venlafaxine hydrochloride (EFFEXOR), levothyroxine (MANUFACTURER UNKNOWN), ibuprofen (MANUFACTURER UNKNOWN), Pro tonic (MANUFACTURER UNKNOWN); all taken for an unspecified indication from an unspecified date to an unspecified date. The patient previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; first dose -Lot Number: Ek9231, intramuscularly in the left arm) on 28Dec2020 at 49-years-old. On 18Jan2021 at 16:00, the patient experienced fatigue (non-serious), chills (non-serious), body aches (non-serious), headache (non-serious); with no treatment received. The clinical outcome of the events was not recovered. The patient did not receive any other vaccine in four weeks prior to the COVID-19 vaccine. The patient did not have COVID prior to vaccination. The patient was not tested for COVID post vaccination..

Other Meds: EFFEXOR; LEVOTHYROXINE; IBUPROFEN

Current Illness:

ID: 0993525
Sex: F
Age:
State: PA

Vax Date: 01/18/2021
Onset Date: 01/19/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Pregnant at the time of vaccination?: Yes/gestational period:6/ mother was 8 Weeks pregnant at the onset of the event; Pregnant at the time of vaccination?: Yes/gestational period:6/ mother was 8 Weeks pregnant at the onset of the event; Pregnant at the time of vaccination?: Yes/gestational period:6/ mother was 8 Weeks pregnant at the onset of the event; Nausea; Vomiting; Severe myalgias; Headache; This is a spontaneous report from a contactable physician reporting for herself. A 29-years-old female pregnant patient received the second dose of bnt162b2 (BNT162B2), lot number EL0142, via an unspecified route of administration from 18Jan2021 15:00 (at the age of 29-years-old) as a single dose in the left arm for COVID-19 vaccination. Historical vaccine included first dose of bnt162b2 (BNT162B2), lot number EL1284 in the left arm. The patient's medical history was not reported. Concomitant medication included multivitamin. The patient previously took clarithromycin(BIAXIN) and experienced Known allergies: BIAXIN. No other vaccine was given in four weeks. The patient received the vaccine at a hospital. The patient's last menstrual date was 23Nov2020. Her Delivery date is 01Sep2021. Gestational period is 6. The mother was 8 Weeks pregnant at the onset of the event. On 19Jan2021 at 03:00 the patient experienced nausea, vomiting, severe myalgias and headache. Treatment included acetaminophen (TYLENOL) and antiemetic. The clinical outcomes of the events nausea, vomiting, severe myalgias and headache was recovering. The clinical outcome of the event "Pregnant at the time of vaccination?: Yes/gestational period:6/ mother was 8 Weeks pregnant at the onset of the event" was unknown. Prior to the vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19.

Other Meds:

Current Illness:

ID: 0993526
Sex: F
Age:
State:

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: body temperature; Result Unstructured Data: Test Result:low grade fever (100 degrees)

Allergies:

Symptoms: Extreme weakness; gastro issues; she had a low grade fever; This is a spontaneous report from a contactable consumer. This consumer reported for a 73-year-old female patient received first dose of bnt162b2 (COVID 19, Pfizer), via unknown route of administration on Jan2021 at single dose for covid-19 immunisation. Medicla history was unknown. No Known allergies. Concomitant medications included other vaccine in 4 weeks product for Shingles. Facility type vaccine was other. The patient experienced Extreme weakness and gastro issues from Jan2021. She had a low grade fever (100 degrees) from Jan2021. Yesterday she mentioned she is feeling better than the initial reaction but not yet 100%. The outcome of the event was recovering. No treatment received. No COVID prior vaccination. No COVID tested post vaccination. Information about Lot/Batch number is requested.

Other Meds:

Current Illness:

ID: 0993527
Sex: F
Age:
State: FL

Vax Date: 01/12/2021
Onset Date: 01/16/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Very strong pins/needles throughout body; This is a spontaneous report from a contactable consumer reporting for self. A 65-year-old female received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 12Jan2021 (at the age of 65-years-old) 17:00 as a single dose, left arm for COVID-19 immunization. The patient was not pregnant at the time of vaccination. Medical history included high blood pressure, arrythmia, high sugar, and penicillin allergy. The patient was not diagnosed with COVID prior to vaccination. Concomitant medication included metoprolol succinate (TOPROL), lisinopril, amlodipine, and esomeprazole sodium (NEXIUM). On 16Jan2021 at 10:00, the patient experienced very strong pins/needles throughout body. There was no treatment provided for the event. The outcome of the event very strong pins/needles throughout body was not recovered. The patient was not COVID-tested post vaccination. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds: TOPROL; LISINOPRIL; AMLODIPINE; NEXIUM [ESOMEPRAZOLE SODIUM]

Current Illness:

ID: 0993528
Sex: F
Age:
State:

Vax Date: 01/08/2021
Onset Date: 01/01/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data: Test Date: 202005; Test Name: covid antibody; Result Unstructured Data: Test Result:graph show that they decreased a little each time; Test Date: 202101; Test Name: covid antibody; Result Unstructured Data: Test Result:they are the lowest they have been yet at 0.7

Allergies:

Symptoms: rechecked my antibody levels after my second dose and they are the lowest they have been yet at 0.7; This is a spontaneous report from a contactable healthcare professional (patient). A female patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot: EL1283), via an unspecified route of administration on 08Jan2021 at a single dose for COVID-19 immunization. Medical history included covid-19 from May2020. The patient's concomitant medications were not reported. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot: EH9899, expiry: unknown) on 18Dec2020 for COVID-19 immunization. The patient had Covid back in May2020 and she had her antibodies checked all along since having Covid. Her antibody levels on a graph show that they decreased a little each time, but she rechecked her antibody levels after her second dose and they are the lowest they have been yet at 0.7 (Jan2021). The outcome of the event was unknown.

Other Meds:

Current Illness:

ID: 0993529
Sex: U
Age:
State: FL

Vax Date:
Onset Date:
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: stroke; This is a spontaneous report from a contactable physician via a sales representative. A patient of unspecified age and gender received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The physician reported an employee of (institute name) suffered a stroke within a week of taking the Pfizer Covid Vaccine on an unknown date. Dr. (Name) told the physician that he didn't think it was related. The event outcome was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Very limited information is currently available. As the reported stroke occurred within a week of taking the Covid Vaccine, BNT162B2, the Company cannot completely exclude the possible causality between the reported event and the administration of the suspect. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RA, IEC, as appropriate.

Other Meds:

Current Illness:

ID: 0993530
Sex: M
Age:
State:

Vax Date: 12/29/2020
Onset Date: 01/01/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: intense headaches; Chills; This is a spontaneous report from a contactable consumer (patient). A 40-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 29Dec2020 at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced intense headaches and chills in Jan2021. Caller stated he received the 1st dose of COVID vaccine on 29Dec2020 and experienced no side effects up until yesterday (Jan2021) wherein he experienced intense headaches and chills. The patient wanted to know if it's normal to experience this a few days after getting the vaccine and if there is a similar case that has been reported. The outcome of the events was unknown. Information on the Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0993531
Sex: F
Age:
State: AR

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: GI reaction with spasms; GI reaction with spasms; bloating and uncomfortable like you over eat and have tight pants in; bloating and uncomfortable like you over eat and have tight pants in; This is a spontaneous report from a contactable consumer (patient). A 57-year-old female consumer received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 11Jan2021 at 04:30PM in left arm at single dose for COVID-19 immunisation at the age of 57-year-old. Lot number was 59267-1000-01. Medical history included no gall bladder, ongoing bloating and uncomfortable like you over eat and have tight pants in on 11Jan2021 at 02:00PM. Patient was not pregnant. Past drug history included allergy to codeine. Concomitant medications included venlafaxine, verapamil, tocopherol (VITAMIN E), ascorbic acid, biotin, folic acid, iodine, pantothenic acid, pyridoxine hydrochloride, retinol, vitamin b12 nos, vitamin d nos, vitamin e nos, zinc (CENTRUM), atenolol (ALTENOL), zopidem tartrate (ZOLPIDEM). On 11Jan2021 at 02:00PM (also reported: wishing 2 minutes, as reported), inside stomachs and gut, the patient felt it spread over that area (not warm, not painful, weird) and afterwards that night bloating and uncomfortable like you over eat and have tight pants in, then the next day (on 12Jan2021, also reported on 11Jan2021 at 02:00PM, as reported) she had a gastro-intestinal (GI) reaction with spasms that were very painful (something that happens very seldom and the patient was sitting at her desk working so no irritable factors) so she had to take strong meds because this GI spasm was very painful and hurt when you breath, so she took strong medication (hyosymin and mepitab). The patient recovered with lasting effects from abdominal distension, the patient recovered from other events.

Other Meds: VENLAFAXINE; VERAPAMIL; VITAMIN E [TOCOPHEROL]; CENTRUM MULTIGUMMIES; ALTENOL; ZOPIDEM

Current Illness: Bloating (at 02:00PM)

ID: 0993532
Sex: F
Age:
State: NC

Vax Date: 12/29/2020
Onset Date: 01/01/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: COVID; Result Unstructured Data: Test Result:developed covid; Comments: She developed COVID 5 days after getting the 1st dose-Received the 1st dose 29Dec2020

Allergies:

Symptoms: Still experiencing upper respiratory congestion; She developed COVID 5 days after getting the 1st dose; She developed COVID 5 days after getting the 1st dose; This is a spontaneous report from a contactable consumer from a Pfizer-sponsored program. A female patient of an unspecified age(reported as Age: 66, Unit: Unknown) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 29Dec2020 at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient developed COVID 5 days after getting the 1st dose, she received the 1st dose on 29Dec2020 and due for 2nd dose on 19Jan2021. The patient was still experiencing upper respiratory congestion. She had the initial dose of the vaccine 3 weeks before and a week after her first dose, she developed Covid, she had been exposed so it just so happened, The patient was 14 days out from having COVID. She was scheduled to get the 2nd dose at the time of the report and was wondering if she needed to postpone it. The outcome of event "still experiencing upper respiratory congestion" was not recovered, of other events was unknown. ? Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0993533
Sex: F
Age:
State: WV

Vax Date: 12/01/2020
Onset Date: 12/15/2020
Rec V Date: 02/02/2021
Hospital:

Lab Data: Test Date: 20201215; Test Name: COVID test; Test Result: Positive ; Comments: on 15Dec2020 had a positive COVID test, contracted Sars-Cov-2

Allergies:

Symptoms: first dose of bnt162b2 on 01Dec2020, patient was due for their second dose 30Dec2020; first dose of bnt162b2 on 01Dec2020, patient was due for their second dose 30Dec2020; patient had a positive COVID test, contracted Sars-Cov-2; patient had a positive COVID test, contracted Sars-Cov-2; This is a spontaneous report from a contactable Nurse from a Pfizer-sponsored program. A 48-year-old female patient received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine), via an unspecified route of administration on 01Dec2020 at a single dose for COVID-19 immunization. There was none medical history or concomitant medications. The patient received the vaccine on 01Dec2020, and then on 15Dec2020, patient had a positive COVID test, contracted Sars-Cov-2, and was due for their second dose 30Dec2020. She was supposed to get her second dose at the end of Dec2020, but she did not return. She stated they were caught in the middle. The patient did return for her second dose with her employer, but they turned her away. The patients second dose was supposed to be on 30Dec2020. Suspect product: Caller does not have the NDC, lot, or expiration date to provide from the first dose that the patient received. There was a Product Complaint. This is a non-serious report. The outcome of events was unknown. Information on the lot/batch number has been requested.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported events of COVID-19 and suspected LOE due to temporal relationship. There is limited information provided in this report. This case will be reassessed once additional information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0993534
Sex: F
Age:
State: MI

Vax Date: 01/03/2021
Onset Date: 01/18/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: noticed 3 lumps the size of finder tip on her shoulder that were red and itchy; noticed 3 lumps the size of finder tip on her shoulder that were red and itchy; noticed 3 lumps the size of finder tip on her shoulder that were red and itchy; This is a spontaneous report from a contactable consumer reported for self. This 60-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot#: EK9231) at single dose on left arm on 03Jan2021 at 0830AM for COVID-19 immunisation. History of all previous immunization with the Pfizer vaccine considered as suspect was none. Medical history was none. Family medical history was none. Relevant test was none. Prior Vaccinations (within 4 weeks) was none. There was no concomitant medication. Patient received 1st dose on 03Jan2021. Yesterday (18Jan2021), she noticed 3 lumps the size of finder tip on her shoulder that were red and itchy. Across her cleavage, she noticed another 3-4 lumps. She noticed last night, 18Jan2021, three lumps on her shoulder that were really itchy and red and three or four across her cleavage area but not as large. She was just checking, she knew it said could have swollen lymph glands. Patient mentioned she tried to set the phone thing set up where they call you but she could not do it. The shoulder lumps were on her left side and about the size of tip of her little finger. She tried Witch Hazel; she rubbed it on and that soothed it a little at that time. she was scheduled for the second dose of the vaccine on the 25Jan2021. Patient asked if this was normal and what could the end result possibly be. The adverse events did not require a visit to physician or ER. The outcome of events was not resolved.

Other Meds:

Current Illness:

ID: 0993535
Sex: M
Age:
State: TN

Vax Date: 01/14/2021
Onset Date: 01/15/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data: Test Date: 20210115; Test Name: Body temperature; Result Unstructured Data: Test Result:102.7; Test Date: 20210115; Test Name: Heart rate; Result Unstructured Data: Test Result:140

Allergies:

Symptoms: drenching sweated for another 5 hours; diarrhea; rigors; fever to 102.7; tachycardia to 140 which all lasted for 30 minutes; This is a spontaneous report from a contactable physician reporting for self. A 54-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1283), via an unspecified route of administration on 14Jan2021 11:00 at single dose for COVID-19 immunization. Medical history included asthma, covid-19 from an unknown date. Patient received first dose of bnt162b2 on 17Dec2020. Concomitant medication included albuterol [salbutamol] (ALBUTEROL [SALBUTAMOL]), fluticasone propionate (FLOVENT). On 15Jan2021 22:00, 36 hours after second vaccine patient had diarrhea, then rigors, fever to 102.7, tachycardia to 140 which all lasted for 30 minutes. After it stopped had drenching sweated for another 5 hours and more diarrhea. Fever lasted for 1 hour after taking Tylenol and Alleve. Felt back to normal next morning and fine since. No symptoms now. Outcome of events was recovered.

Other Meds: ALBUTEROL [SALBUTAMOL]; FLOVENT

Current Illness:

ID: 0993536
Sex: F
Age:
State: SC

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Seizure; muscle spasm; weakness; hard to breathe at time; can't stay awake; This is a spontaneous report from a contactable nurse (patient). A 28-year-old female patient (not pregnant) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL3346), via an unspecified route of administration at Left arm on 15Jan2021 08:00 at single dose for covid-19 immunization. Medical history included seizure, asthma, known allergies to penicillins and NSAIDs. Concomitant medication included levetiracetam, escitalopram, phenytoin, lamotrigine. The patient previously took naproxen, azithromycin, clindamycin; all experienced drug hypersensitivity. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 15Jan2021 at time of 08:30, the patient experienced seizure, muscle spasm and weakness, hard to breathe at time, can't stay awake. Events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No treatment received for the events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of the events was not recovered.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the seizure and other reported events due to temporal relationship. Of note, the patient has a medical history of seizure disorder. There is limited information provided in this report. Additional information is needed to better assess the case, including complete medical history, diagnostics, counteractive treatment measures and concomitant medications. This case will be reassessed once additional information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds: LEVETIRACETAM; ESCITALOPRAM; PHENYTOIN; LAMOTRIGINE

Current Illness:

ID: 0993537
Sex: F
Age:
State: MI

Vax Date: 01/16/2021
Onset Date: 01/18/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Became extremely dizzy Monday night, 48 hours after receiving the vaccine.; This is a spontaneous report from a contactable consumer. A 40-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot:EL3249), via an unspecified route of administration on 16Jan2021 16:15 at a single dose for covid-19 immunization. The patient's medical history included migraine (migraine headaches) from an unknown date and unknown if ongoing. The patient has no known allergies. Concomitant medications included apple cider vinegar, butalbital, caffeine, paracetamol (FIORICET) and multi-vitamin. On 18Jan2021 at 21:15, the patient became extremely dizzy Monday night, 48 hours after receiving the vaccine. The episode was brief and went away, but was very scary, as this has never happened before. The patient did not received treatment for the event. The outcome of the event was recovered in Jan2021. The patient has not had vaccine in four weeks. The patient has not had Covid prior to vaccination and not tested for Covid post vaccination.

Other Meds: APPLE CIDER VINEGAR; FIORICET

Current Illness:

ID: 0993538
Sex: F
Age:
State:

Vax Date: 12/23/2020
Onset Date: 12/27/2020
Rec V Date: 02/02/2021
Hospital:

Lab Data: Test Date: 20201227; Test Name: tested positive for Covid; Test Result: Positive

Allergies:

Symptoms: tested positive for Covid; tested positive for Covid; This is a spontaneous report from a contactable nurse (reporting for herself). A female patient of unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE lot number and expiration date not reported), via an unspecified route of administration on 23Dec2020 as a single dose for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient reported that she received her first dose on "23Dec and on 27Dec tested positive for Covid". The clinical outcome of the events tested positive for Covid was unknown. The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.; Sender's Comments: Based on the mechanism of action of BNT162B2 vaccine, it is unlikely the patient would have fully developed immunity for the vaccine to be effective, due to the number of days passed since the vaccine was given (4 days in this case). However, a causal relationship between event "tested positive for Covid " (coded to Drug ineffective / COVID-19) and BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) cannot be completely excluded.

Other Meds:

Current Illness:

ID: 0993539
Sex: F
Age:
State: NY

Vax Date: 01/04/2021
Onset Date: 01/12/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data: Test Date: 20210112; Test Name: Covid test; Test Result: Positive

Allergies:

Symptoms: tested positive for COVID-19; tested positive for COVID-19; This is a spontaneous report from a contactable nurse. A 58-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not reported), via an unspecified route of administration on 04Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got the first shot of the COVID-19 vaccine on 04Jan2021 then tested positive for COVID-19 on 12Jan2021. Patient was concerned whether she should get the second shot of the COVID-19 vaccine as scheduled or should we wait. The outcome of the event was unknown. Information on the lot/batch number has been requested.; Sender's Comments: Based on the mechanism of action of BNT162B2 vaccine, it is unlikely the patient would have fully developed immunity for the vaccine to be effective, due to the number of days passed since the vaccine was given (8 days in this case). However, a causal relationship between event "tested positive for Covid-19 " (coded to Drug ineffective / COVID-19) and BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) cannot be completely excluded.

Other Meds:

Current Illness:

ID: 0993540
Sex: F
Age:
State: MD

Vax Date: 01/08/2021
Onset Date: 01/15/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Minor left arm pain at injection site for 24h; malaise for 24h; Left supraclavicular lymphadenopathy (multiple swollen nodes); This is a spontaneous report from a contactable physician reporting for herself. A 32-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot #: EL3246), via an unspecified route of administration on 08Jan2021 at 11:45 (at the age of 32-years-old) as a single dose in the left arm for COVID-19 vaccination. Medical history was reported as none. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included drospirenone, ethinylestradiol (OCELLA) taken for birth control from an unspecified date and unspecified if ongoing (reported as taken in two weeks). The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took acetylsalicylic acid (ASPIRIN) from an unspecified date to an unspecified date for an unspecified indication and experienced allergy. On 15Jan2021 at 12:00, the patient experienced "minor left arm pain at injection site for 24h", "malaise for 24h" and "left supraclavicular lymphadenopathy (multiple swollen nodes)". The clinical course was reported as follows: "Minor: left arm pain at injection site for 24h and malaise for 24h, left supraclavicular lymphadenopathy (multiple swollen nodes) noticed 7 days after vaccination and still present 11 days after vaccination." It was unknown whether the patient received treatment for the events. The clinical outcomes of the events "minor left arm pain at injection site for 24h", "malaise for 24h" and "left supraclavicular lymphadenopathy (multiple swollen nodes)" were all not recovered/not resolved. It was also reported that since the vaccination, the patient had not been tested for COVID-19.

Other Meds: OCELLA

Current Illness:

ID: 0993541
Sex: F
Age:
State: GA

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data: Test Date: 20210115; Test Name: Fever; Result Unstructured Data: Test Result:101.4

Allergies:

Symptoms: Fatigue; headache; earache; sore throat; fever of 101.4 for 24 hours; Diarrhea; Could do nothing but sleep; administration date=15Jan2021 (dose number: 2); administration date=23Dec2020 (dose number=1); This is a spontaneous report from a contactable other health professional (patient). A 60-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EK9231), via an unspecified route of administration on 15Jan2021 at 13:30 at a single dose in the left arm for COVID-19 immunization. The patient's medical history included allergies when younger, known allergies to wheat, dairy, cats, and mold. There were no concomitant medications. The patient previously took levofloxacin (LEVAQUIN) and nitrous oxide and experienced allergies; also had her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EK9231) on 23Dec2020 at 11:30 for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. On 15Jan2021, the patient experienced fatigue, headache, earache, sore throat, and fever of 101.4 for 24 hours, and diarrhea. The patient could do nothing but sleep. The patient did not receive any treatment for the reported events. The patient was not pregnant at the time of vaccination. The outcome of the events was recovering.

Other Meds:

Current Illness:

ID: 0993542
Sex: M
Age:
State: TN

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data: Test Date: 20210119; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Pending

Allergies:

Symptoms: mild bilateral tinnitus/the tinnitus has significantly been exacerbated; This is a spontaneous report from a contactable Other Health Professional (patient). This 25-year-old male received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EL1283 and Expiration date unspecified) on 12Jan2021 13:00 (at 25 years of age) intramuscular into right arm as single dose for COVID-19 immunisation. Medical history was reported as none. There was no reported allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to BNT162B2. Concomitant medications were not reported. On 12Jan2021 13:15, the patient experienced mild bilateral tinnitus/the tinnitus has significantly been exacerbated. Patient started having very mild bilateral tinnitus 15 minutes after Covid Vaccine and was not concerned, however by 18Jan2021 the tinnitus has significantly been exacerbated. No treatment was provided. Lab data included Nasal Swab done 19Jan2021 with pending results which was post vaccination. Outcome of event mild bilateral tinnitus/the tinnitus has significantly been exacerbated was not recovered.

Other Meds:

Current Illness:

ID: 0993543
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: lip tingling; This is a spontaneous report from a non-contactable nurse (patient). This female patient of unspecified age received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and Expiration date unspecified) on unspecified date as single dose for COVID-19 immunisation. Medical history included anxiety, heart was pounding, and palms were sweaty long before the shot. Concomitant medications were not reported. The patient experienced lip tingling on an unspecified date. Tingling lasted moments not even full minute and went away. Patient is asking if lip tingling with no itchiness and no swelling, is considered anything of concern or in someone without any adverse reactions like anaphylaxis. She already talked to her physician/allergist and was told that event was due to anxiety and panic. She wants to get her second dose of the vaccine but the pharmacist at her employer are reluctant to give it. Outcome of event lip tingling was recovered. No follow-up attempts are possible. Information about Lot/Batch cannot be obtained.

Other Meds:

Current Illness:

ID: 0993544
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: felt a little warmth in the body; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number requested) via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. Medical history included ongoing arthritis. Concomitant medication included methotrexate (manufacturer unknown) for arthritis. The patient was taking methotrexate 0.8ml once a week for arthritis and on an unspecified date (reported as Saturday) received the COVID vaccine. He wanted to know if he can resume his therapy with methotrexate before getting the second dose. He stated that he just felt a little warmth in the body on an unspecified date. The outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds: METHOTREXATE

Current Illness: Arthritis

ID: 0993545
Sex: F
Age:
State: NC

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data: Test Date: 20201216; Test Name: tested positive for the covid virus; Test Result: Positive

Allergies:

Symptoms: fever; lymph node around my ears are still kind of icky/swollen; This is a spontaneous report from a contactable consumer (patient). A 66-years-old female patient received the first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) , via an unspecified route of administration on unspecified date in Jan2021 at single dose for covid-19 immunisation. Medical history included tested positive for the covid virus from 16Dec2020. The patient's concomitant medications were not reported. The patient experienced fever and lymph node around ears are still kind of icky and swollen in Jan2021. The outcome of event fever was not recovered; outcome of other event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0993546
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: head heaviness; felt like fainting; chest heaviness; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age (78 unit unspecified) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date unknown) via unspecified route of administration on unspecified date at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient wanted to know if she can get the 2nd dose of the vaccine since she was experiencing few side effects, head heaviness, felt like fainting, chest heaviness. The patient was unsure if it was due to vaccine. The outcome of the events head heaviness, felt like fainting, chest heaviness was unknown. Follow-up activities are possible, information on the batch number has been requested.

Other Meds:

Current Illness:

ID: 0993547
Sex: F
Age:
State: FL

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: swollen arm as a side effect/Right arm swelling; This is a spontaneous report from a contactable consumer (patient). A 79-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number (Lot number reported either EL8982, LL8982, or 6L8982), expiration date unknown), via an unspecified route of administration in the right arm on 15Jan2021 at 14:30 to at a single dose for COVID-19 immunisation. Medical history and family medical history were reported none. The patient had no prior vaccinations within four weeks. There were no concomitant medications. On 15Jan2021, the patient experienced swollen arm as a side effect/ right arm swelling. It was reported that right arm swelling began in the evening. It was also reported that arm was still swollen, but has gotten a little better. The patient asked how long that will last, how to treat the swelling, and if she can go for the second inoculation. The outcome of the event was recovering. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0993548
Sex: F
Age:
State:

Vax Date: 01/16/2021
Onset Date: 01/17/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: fever; myalgias; headaches; This is a spontaneous report from a non-contactable physician (patient, who is a healthcare provider/oncologist). A 43-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), via an unspecified route of administration in left arm on 16Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included first dose of PFIZER BIONTECH COVID-19 VACCINE given on 26Dec2020 in the left arm for COVID-19 immunization. She is not pregnant. The patient had no covid prior vaccination. The patient had no covid prior vaccination and she had not tested for covid post vaccination. On 17Jan2021, a day after receiving the second dose, patient said that she was down all day in bed with fever and myalgias and headaches. After taking ibuprofen, she felt better. Therapeutic measure was taken as a result of the events. The outcome of the events was recovered in Jan2021. No follow up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0993549
Sex: F
Age:
State: MN

Vax Date: 12/22/2020
Onset Date: 01/10/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: pain at the injection site; fatigue; spacey; This is a spontaneous report from a contactable consumer (patient). A 57-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EJ1685), via an unspecified route of administration on 22Dec2020 at 15:00 at a single dose in the left arm to prevent Covid. The patient's medical history included ongoing blood pressure high, ongoing cholesterol, ongoing anxiety, and ongoing sleep disorder. Concomitant medications included pravastatin for cholesterol, amlodipine besylate for blood pressure high, lisinopril for blood pressure high, zolpidem tartrate (AMBIEN CR) for sleep, olanzapine for anxiety, all ongoing. On 10Jan2021, the patient noticed feeling fatigue and spacey. On an unspecified date, the patient stated that she did get some pain at the injection site and took Aleve 2 capsules as needed. The patient considered the events fatigue and spacey as non-serious. The outcome of the events fatigue and spacey was recovered on 10Jan2021, while unknown for the other event.

Other Meds: PRAVASTATIN; AMLODIPINE BESYLATE; LISINOPRIL; AMBIEN CR; OLANZAPINE

Current Illness: Anxiety; Blood cholesterol abnormal; Blood pressure high; Sleep disorder

ID: 0993550
Sex: F
Age:
State: NY

Vax Date: 12/31/2020
Onset Date: 01/01/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: elevated redness sort of like a rash around the injected area; rash came back in the injected area; it was itchy; my face was swollen and ears; my face was swollen and ears; hives on my face; skin was very dry; rash like; This is a spontaneous report from a contactable healthcare professional reporting for a patient. A 28-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), intramuscular in the left arm on 31Dec2020 at 14:00 (at the age of 28-years-old) as a single dose for Covid-19 immunization. Medical history included tuberculosis (TB) when younger and took medication for it from an unknown date. The patient was allergic to penicillin and breaks out in hives and a rash. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications included spironolactone (MANUFACTURER UNKNOWN) for unknown indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date after the vaccination, the patient experienced elevated redness sort of like a rash around the injected area for 2 days and then it went away, exactly a week later the rash came back in the injected area but did not spread and lasted another two days. On 14Jan2021 at 04:00 the patient experienced broke up in hives on face, face was swollen, and ears and it was itchy. The patient experienced skin was very dry and rash like but not itchy on an unknown date in Jan2021. Therapeutic measures were taken for the swelling face, ear swelling, hives and pruritis which included Benadryl for 2 days which helped the events go down. The clinical outcome of the event injection site erythema, swelling face, ear swelling, hives and pruritus was recovered; injection site rash, dry skin and rash were unknown. It was reported that since the vaccination, the patient had not been tested for COVID-19. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported events of COVID-19 virus test positive and suspected LOE due to temporal relationship. There is limited information provided in this report. Additional information is needed to better assess the case, including complete medical history, diagnostics, counteractive treatment measures and concomitant medications. This case will be reassessed once additional information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds: SPIRONOLACTONE

Current Illness:

ID: 0993551
Sex: F
Age:
State: NJ

Vax Date: 01/16/2021
Onset Date: 01/17/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data: Test Name: Body temperature; Result Unstructured Data: Test Result:100 Fahrenheit

Allergies:

Symptoms: I felt extremely hot/cold sensation in a claustrophobic; I felt extremely hot/cold sensation in a claustrophobic; nauseous; Dizzy; headache; fatigue/I'm just exhausted 72 hours later; fever kept rising; I started violently projectile vomiting for a few hours; I got the chills; I was sore; felt "hungover"; the arm soreness; This is a spontaneous report from a contactable healthcare professional. A 40-year-old female patient received her second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EK9231) on her right arm, intramuscular on 16Jan2021 14:15 at a single dose for COVID-19 immunization. Medical history included anxiety, acid reflux and cholecystectomy. Concomitant medication included bupropion hydrochloride (WELLBUTRIN), escitalopram oxalate (LEXAPRO), clonazepam (CLONAPAM) and an unspecified antacid. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on 28Dec2020 as first dose. It was reported that 12 hours later after vaccination, the patient felt really hot and nauseous, dizzy, headache and fatigue. But then 24 hours later her fever kept rising. She felt extremely hot/cold sensation in a claustrophobic. At peak of her fever, 100F, she started violently projectile vomiting for a few hours. Then she got the chills. Felt nauseous still. But no more vomiting, fever went down on its own. The next day 48 hours later, she was sore and felt "hungover". This time the arm soreness dissipated twice as fast. Now she just exhausted 72 hours later; all events occurred on 17Jan2021 at 02:00. No treatment was received for the events. The outcome of the events was recovered with sequel.

Other Meds: WELLBUTRIN; LEXAPRO; CLONAPAM

Current Illness:

ID: 0993552
Sex: F
Age:
State: FL

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Swollen and tender supraclavicular lymph nodes; Swollen and tender supraclavicular lymph nodes; This is a spontaneous report from a contactable other health professional (patient). An adult female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), (lot number: EL1284) via an unspecified route of administration in the left arm, on 13Jan2021 08:30 at SINGLE DOSE for COVID-19 immunization. Medical history included asthma, seasonal allergies and gluten sensitivity. Concomitant medication included montelukast sodium (SINGULAIR) and ethinylestradiol, norethisterone (ORTHO-NOVUM). The patient previously took flexeril [cyclobenzaprine hydrochloride]; and bnt162b2 (first dose; lot number-EH9899, administration date-23Dec2020, 08:30 AM). On 13Jan2021 21:00, the patient experienced swollen and tender supraclavicular lymph nodes. The outcome of events was reported as recovering. Patient did not receive any treatment due to the events. No follow-up attempts are possible. No further information is expected. Information on the lot/batch number has been obtained.

Other Meds: SINGULAIR; ORTHO-NOVUM [ETHINYLESTRADIOL;NORETHISTERONE]

Current Illness:

ID: 0993553
Sex: F
Age:
State:

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: tingling sensation on the left side of her face; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not reported), via an unspecified route of administration on 19Jan2021 09:50 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first dose of the vaccine today at 9:50am and experienced a tingling sensation on the left side of her face at 10:30-10:45am 19Jan2021. It was described as like she had gotten Lidocaine and it's not worn off yet. The sensation was not getting worse but was still there. She was asking if this a normal reaction and on what she should do. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0993554
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: lip tingling; This is a spontaneous report from a contactable nurse (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation. Medical history included before having the shot, she was being anxious as described by feeling nervous, having sweaty palms, her heart was racing, couldn't listen to the lady that was administering the shot, difficulty in concentration. The patient's concomitant medications were not reported. The patient experienced lip tingling that happened momentarily and went away on its own as an adverse event. The action taken in response to the event(s) for bnt162b2 was not applicable. Because of this event, her employer won't let her have the second shot for the COVID-19 vaccine. She had an appointment with her allergist who assured her that her experience was not an anaphylactic reaction and it was not a contraindication to the vaccine. Outcome of the event was unknown. Information on Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0993555
Sex: M
Age:
State: NC

Vax Date: 01/17/2021
Onset Date: 01/17/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: soreness in his hips and back - more sore than usual; soreness in his hips and back - more sore than usual; got rather tired; had a pretty good headache; dizziness when getting up too quickly; heart palpitations; This is a spontaneous report from a contactable consumer (patient himself) via a Pfizer-sponsored program. A male patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; batch/lot number and expiration date were unknown), via an unspecified route of administration on 17Jan2021 at 10:30 at a single dose for COVID-19 immunisation. Relevant medical history included usual soreness in his hips and back. The patient's concomitant medications were not reported. The patient reported he had a few little side effects and that was fine; he was over it at the time of the report. When the injection was given, it was cold going in. There were no side effects for the first 3-4 hours (hrs) after vaccine on 17Jan2021, then after that he got rather tired; in 12 hours, he had a pretty good headache, dizziness when getting up too quickly, and a couple times he did have heart palpitations. On 18Jan2021, the next morning from shot (less than 24 hour after shot), he had soreness in his hips and back, which was more sore than usual. The patient said that by the end of 36 hours, the symptoms resolved. The patient stated he was "48 hours out and he was feeling fine; he might even feel a little better than when he started this whole thing." The patient also stated that the vaccination provider gave him an option for his 2nd dose appointment (days 18-22 post 1st dose). The patient took the earliest appointment, but was wondering at the time of the report, if that would be 'okay' to get the 2nd dose on day 18 or should he call and reschedule for day 21. The patient further reported that he had a Pfizer vaccine shot on Sunday and had a small amount of side effects, but there was no big deal and no problem. They scheduled him for the second shot only 18 days rather than 3 weeks and wanted to check and see if that was something that's ok or that's too close. The patient recovered from all the events on 18Jan2021. Information on the batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 0993556
Sex: F
Age:
State: MD

Vax Date: 12/31/2020
Onset Date: 12/31/2020
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: hives/hives on her lower legs with sporadic patches on other places of her body including her upper legs, some on her arm, some on her torso and her upper chest; soreness (a little bit); This is a spontaneous report from a contactable consumer (patient). A 29-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Unknown lot number and expiration), intramuscular in left upper arm on 31Dec2020 at a single dose for COVID-19 prophylaxis. Medical history included cat allergy/seasonal and animal allergies. Concomitant medication included cetirizine hydrochloride (ZYRTEC) for cat allergy. The patient previously received flu shot for immunization on unspecified date. The patient reported that she received the first dose of vaccine on 31Dec2020 and experienced soreness (a little bit) but was no difference from the flu shot. Last night (18Jan2021), hives started to appear. She took a Zyrtec this morning (19Jan2021) that she usually takes at night to alleviate the symptoms. She takes Zyrtec because she has a cat allergy and also reported to have changed her laundry detergent. The patient was wondering if there have been any reports of delayed allergic reactions to the COVID-19 vaccine. She said that she just got hives on her lower legs with sporadic patches on other places of her body including her upper legs, some on her arm, some on her torso and her upper chest last night. She may have some on her back, but she has not looked yet. She has had this type of reaction before with an antibiotic in the past. She is supposed to get the second dose on Thursday 21Jan2021. She noticed the hives last night and they seem to have gotten a little bit worse overnight but are about the same since she has gotten up. She said that she has allergies, but they are seasonal and animal allergies. She has also been using the same body wash and laundry detergent and stated that nothing has really changed with her. She also said that her partner that lives with her has not had any skin issues. The patient had not yet recovered from the event hives, while unknown outcome for the remaining event. Information on the lot/batch number has been requested.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 0993557
Sex: F
Age:
State:

Vax Date: 01/18/2021
Onset Date: 01/18/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: nausea; heartburn; chills; nightmares; soreness at the back of her neck; headaches; seeing a blank shadow; This is a spontaneous report from a contactable consumer (patient). A female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 18Jan2021 11:00 AM at single dose for COVID-19 immunisation. Caller received the first dose of the Pfizer COVID vaccine yesterday (18Jan2021) at 11am. Last night, she started to experience nausea, heartburn, chills, nightmares, soreness at the back of her neck, headaches and seeing a blank shadow. She is concerned if these are normal side effects associated with the COVID-19 vaccine. Patient reported had a whole lot of things all night long, and wanted to see if they were normal, the side effects. Outcome of the events was unknown. Information about Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0993558
Sex: F
Age:
State: OH

Vax Date: 01/16/2021
Onset Date: 01/17/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Sore at injection site (felt like bruise); Sore at injection site (felt like bruise); This is a spontaneous report from a contactable consumer (patient). A non-pregnant female patient received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3249), via an unspecified route of administration in the right arm on 16Jan2021 15:45 at a single dose for COVID-19 immunization. Medical history included asthma/allergies and eggplant/zucchini sensitivity. The patient's concomitant medications were not reported. The patient experienced sore at injection site (felt like bruise) on 17Jan2021 that lasted approximately 36 hrs. The patient was okay by 18Jan2021 afternoon. Outcome of the events was reported as recovered on 18Jan2021. No treatment was given for the events. The patient was not diagnosed with COVID-19 prior vaccination and has not tested for COVID-19 post vaccination.

Other Meds:

Current Illness:

ID: 0993559
Sex: F
Age:
State: VA

Vax Date: 01/14/2021
Onset Date: 01/18/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: flushing to face and swollen cheeks; flushing to face and swollen cheeks; nausea; vomiting; This is a spontaneous report from a contactable Other Health Professional. A female patient (non-pregnant) received 1st dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 14Jan2021 at single dose for COVID-19 immunisation. Medical history included anxiety, PCOS (polycystic ovarian syndrome), known allergies: sulfa. Concomitant medication included biotin, cannabidiol (CBD OIL), fish oil, ibuprofen, metformin, famotidine (PEPCID AC), spironolactone, ethinylestradiol; ferrous fumarate; norethisterone acetate (TAYTULLA), calcium carbonate (TUMS [CALCIUM CARBONATE]), colecalciferol (VIT D3). The patient experienced flushing to face and swollen cheeks, nausea and vomiting day 4 after vaccine on 18Jan2021 16:00. Therapeutic measures were taken included cetirizine hydrochloride (ZYRTEC) and omeprazole (PRILOSEC). This event resulted in: Doctor or other healthcare professional office/clinic visit. Outcome of the event was not resolved. Information on Lot/Batch number has been requested.

Other Meds: BIOTIN; CBD OIL; FISH OIL; IBUPROFEN; METFORMIN; PEPCID AC; SPIRONOLACTONE; TAYTULLA; TUMS [CALCIUM CARBONATE]; VIT D3

Current Illness:

ID: 0993560
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/02/2021
Hospital:

Lab Data: Test Name: antibodies test; Test Result: Negative

Allergies:

Symptoms: received the second dose of the COVID-19 vaccine/He had tested his patient's antibodies in his commercial laboratory and the result was negative; This is a spontaneous report from a contactable physician. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE Solution for injection lot no. and expiry date not reported), via an unspecified route of administration on an unspecified date at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had his first dose of BNT162B2 on unspecified date for covid-19 immunization. It was reported by the physician that he had a patient who received the second dose of the COVID-19 vaccine and had tested his patient's antibodies in his commercial laboratory and the result was negative. The physician was asking if that was an expected result or should it be positive. The outcome of the event was unknown. Information on the Batch/Lot number has been requested.

Other Meds:

Current Illness:

ID: 0993561
Sex: M
Age:
State: NY

Vax Date: 01/15/2021
Onset Date: 01/16/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: rash; This is a spontaneous report from a contactable consumer (patient's wife). A 73-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3249), via an unspecified route of administration on 15Jan2021 at single dose for COVID-19 immunization. Medical history included pneumonia, penicillin allergy, diabetec and high blood pressure from an unknown date and unknown if ongoing. Concomitant medication included potassium citrate, tamsulosin, glipizide, magnesium sulfate, (6s)-5-methyltetrahydrofolate glucosamine, mecobalamin, pyridoxal phosphate, thioctic acid (PODIAPN), dulaglutide (TRULICITY), carvedilol, rosuvastatin, furosemide, acetylsalicylic acid (BAYER ASPIRIN) , valsartan, ubidecarenone (COQ-10), fluticasone furoate, umeclidinium bromide, vilanterol trifenatate (TRELEGY ELLIPTA), salbutamol sulfate (PROAIR HFA) and apixaban (ELIQUIS). The patient previously took amoxicillin at 1 DF, 2x/day (one tablet by mouth every 12 hours), azithromycin at 250 mg (250mg, take two tablets by mouth and then one tablet by mouth for four days) and prednisone at 20 mg (20mg, three pills daily for three days then two pills daily for four days). It was reported that the patient had rash toes up to neck. The patient's wife was wondering if it was normal for his husband to experience rashing after getting the vaccine. The patient had a rash that started from his feet. It looks like sunburn. It is going up his legs, body, and chest. It started the day after the vaccine. Two weeks ago he went to his pulmonary doctor and he had pneumonia. They gave him prednisone, Amoxicillin, and Azithromycin and both are forms of penicillin which he is allergic to. He hasn't taken it in years. The doctor knew that. She is not sure if the rash if from that. He ended those medications the Friday before the vaccine, 08Jan2021. She is confused. Everyone she calls says they are not sure if it was the medications or the shot. She is trying to get a dermatologist to see the patient. The rash started on 16Jan2021. It has progressively gotten worse. She is wondering if the patient should go back on the fifth for the second vaccine. She is assuming it is the medication. The nurses and doctor don't know. They said take him to the ER. He is not having trouble breathing. If he was having trouble breathing she would take him to the ER. She can't get anyone to look at the rash. She didn't do anything. He is supposed to get the second dose on 05Feb2021. The outcome of the event was not recovered.

Other Meds: POTASSIUM CITRATE; TAMSULOSIN; GLIPIZIDE; MAGNESIUM SULFATE; PODIAPN; TRULICITY; CARVEDILOL; ROSUVASTATIN; FUROSEMIDE; BAYER ASPIRIN; VALSARTAN; COQ-10; TRELEGY ELLIPTA; PROAIR HFA; ELIQUIS

Current Illness:

ID: 0993562
Sex: F
Age:
State: GA

Vax Date: 01/15/2021
Onset Date: 01/18/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: rash in the top of right hand/rash on the left hand; looks like dryness; This is a spontaneous report from a contactable consumer (patient). A 62-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number: EN9899), via an unspecified route of administration on 15Jan2021 at 13:30 on the left arm at a single dose for COVID-19 immunization. Medical history included partial seizures complex, asthma, beginning of heart disease and high cholesterol all from an unknown date and unknown if ongoing. There were no concomitant medications. The patient had no prior vaccination within four weeks. The patient stated she has a rash on the top of her hand right hand and rash on the left hand; it is real dry, it looks like dryness, on 18Jan2021. The patient stated that she doesn't know if it is allergic reaction. She needs help to figure it out. She is asking if she needs to see her doctor. The patient stated that otherwise, the vaccine was healing her and helping her. She stated that she knows you can have a rash all over your body and she wants to know if that is going to happen. She clarified she noticed the rash on the top of her right hand - not the palm. She isn't sure if it came from taking out the trash or cleaning stuff or some other reason. She stated that it is now trying to get on the other left hand too. She said you can't really tell it on her left hand but she noticed it on the night of 18Jan2021. She is unsure if when she washes her hands it is getting from the right hand onto the left hand. She just needs to know if it is from the vaccine or if she needs to stop taking out the trash or maybe wearing gloves. She is scheduled to receive the next dose on 5Feb2021. She lives in a senior facility building. One of the staff members got COVID so they had to get the vaccine. The adverse event did not require a visit to the physician or emergency department (ER). The outcome of the events was not recovered.

Other Meds:

Current Illness:

ID: 0993563
Sex: F
Age:
State: MA

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data: Test Date: 20210108; Test Name: temperature; Result Unstructured Data: Test Result:greater than 100 degrees; Comments: greater than 100 degrees topical

Allergies:

Symptoms: nausea; vomiting; rigors; temperature greater than 100 degrees topical; headache; muscle ache; This is a spontaneous report from a contactable health care professional nurse, the patient. A 67-years-old non-pregnant female patient (nurse) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE Lot Number: EK9231,), intramuscular in the left arm on 07Jan2021 16:00 as a single dose, for COVID-19 vaccination. Medical history included gastrooesophageal reflux disease. Concomitant medication included diltiazem (DILTIAZEM). Patient has no known allergies. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE Lot number EH9899, on 18Dec2020; 16:00, Intramuscular, right arm,. On 08Jan2021 at 04:00 the patient experienced nausea, vomiting, rigors, temperature greater than 100 degrees topical, headache, muscle ache. The events resulted in a Physician office visit. Lab tests included body temperature: greater than 100 degrees on 08Jan2021. Treatment given include zofran, APAP, fluids, and rest. The clinical outcome of nausea, vomiting, rigors, temperature greater than 100 degrees topical, headache, muscle ache was recovering.

Other Meds: DILTIAZEM

Current Illness:

ID: 0993564
Sex: F
Age:
State:

Vax Date: 01/15/2021
Onset Date: 01/16/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: flu; fever; chills; body ache; fatigue; This is a spontaneous report from a contactable healthcare professional. A 66-year-old female patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL3248) on her left arm, via an unspecified route of administration on 15Jan2021 15:00 at a single dose for COVID-19 immunization. Medical history included Allergies, Asthma, Sleep Apnea, Obesity, IBS, Depression and Arthritis. Concomitant medication included paroxetine hydrochloride (PAXIL), buspirone, unspecified allergy shots. The patient experienced Flu, Fever, Chills, Body Aches, Fatigue; all on 16Jan2021 09:45. No treatment was received for the events. The outcome of the events was recovered on an unspecified date in Jan2021.

Other Meds: PAXIL [PAROXETINE HYDROCHLORIDE]; BUSPIRONE

Current Illness:

ID: 0993565
Sex: M
Age:
State: MI

Vax Date: 12/30/2020
Onset Date: 12/31/2020
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: sore arm; fatigue; This is a spontaneous report from a contactable physician (patient). A 67-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EK-9231) via an unspecified route of administration into the left arm on 30Dec2020 07:30 at a single dose for covid-19 immunization. Medical history included hypertension, hypercholesterolaemia and psoriasis. Concomitant medication included amlodipine (AMLODIPINE), atorvastatin (ATORVASTATIN), acetylsalicylic acid (BABY ASPIRIN), ergocalciferol (VIT D) and cyanocobalamin (VIT B12). The patient experienced sore arm and fatigue on 31Dec2020 06:30. The patient did not receive treatment for the events reported. Outcome of events recovered on an unspecified date.

Other Meds: AMLODIPINE; ATORVASTATIN; BABY ASPIRIN; VIT D; VIT B12

Current Illness:

ID: 0993566
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Allergic reaction, sensation of throat closing requiring benadryl; Allergic reaction, sensation of throat closing requiring benadryl; This is a spontaneous report from a non-contactable physician. A 47-year-old female patient (non-pregnant) received 2nd dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine included 1st dose of bnt162b2 for COVID-19 immunisation. The patient experienced allergic reaction, sensation of throat closing requiring diphenhydramine hydrochloride (BENADRYL). Event resulted in emergency room/department or urgent care. Therapeutic measures were taken included diphenhydramine hydrochloride and famotidine (PEPCID). Outcome of the event was resolved. No follow up attempts are possible. Information about Lot/ Batch could not be obtained.

Other Meds:

Current Illness:

ID: 0993567
Sex: U
Age:
State:

Vax Date: 01/15/2021
Onset Date: 01/16/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: hives; This is a spontaneous report from a contactable healthcare professional (patient). A patient of unspecified age and gender received second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot/batch number and expiry date were unknown), via an unspecified route of administration on 15Jan2021 at a single dose for COVID-19 immunization. The second dose of vaccine was administered in a hospital setting. The patient's medical history and concomitant medications were not reported. The patient developed hives on 16Jan2021. Antihistamine was given in hospital and was sent home. On 17Jan2021, the event did not improve and was directed to HCP. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0993568
Sex: F
Age:
State:

Vax Date: 12/31/2020
Onset Date: 01/12/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data: Test Date: 20210112; Test Name: covid-19; Test Result: Positive

Allergies:

Symptoms: nausea; diarrhea; fatigue; loss of taste and smell; loss of taste and smell; stomach upset; tested positive for COVID-19; tested positive for COVID-19; This is a spontaneous report from a contactable consumer (patient). A 25-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular on 31Dec2020 at single dose at left arm for covid-19 prophylaxis. There were no medical history and concomitant medications. Patient said that she got the first dose on 31Dec2020. She stated that she got Covid 2 weeks later. She said that she positive test on 12Jan2021. She stated that she was still having mild symptoms of Covid. She said that because of that, she was not cleared to go back to work yet. She stated that she was not having fever or shortness of breath. Patient clarified that her covid-19 symptoms were stomach upset, nausea, diarrhea, loss of taste and smell, and fatigue. She was supposed to get the second dose on 19Jan2021. Outcome of all events was recovering. Information about Batch/Lot number has been requested.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm